Details for 2023202190

Up to date per 01.04.2026

Actions

Title / Product Name

NEUE VERWENDUNG EINER KOMBINATION EINES ANGIOTENSINREZEPTORBLOCKERS (ARB) MIT EINEM NEUTRALEN ENDOPEPTIDASEHEMMER (NEPI)

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2023202190

EP Publication Number

4321157

E-Number

1734267

Language

PCT Number

Publication Date

14.02.2024 A

23.10.2024 B1

Registration Date

23.10.2024

AT Publication Date

15.11.2024

Application Date

26.08.2014

Registration Number

Priorities

26.08.2013

PCT/US2013/056680

31.03.2014

201461972933 P

IPC

A61K 31/194 20060101AFI20240703BHEP

Maximum Duration of Protection

26.08.2034

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT

Inventor

SHI, Victor Chengwei New JerseyUS

LEFKOWITZ, Martin New JerseyUS

RIZKALA, Adel Remond New JerseyUS

Information about Fees